Concepedia

E. Nueesch

EN

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2017

Affiliations

Roche (Switzerland)(Current)

Seoul National University Hospital

University of California, Irvine

Sungkyunkwan University

Chinese University of Hong Kong

E. Nueesch is an author at Roche (Switzerland) specializing in medicine, radiation oncology, and pharmacology.

Top concepts

Publications per year

2017–2020

4

Publications

4

Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer

Peter N. Morcos, E. Nueesch, Félix Jaminion et al. · Cancer Chemotherapy and Pharmacology · 2018 · 28 citations · Full text

1025MO First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours

Ignacio Melero, Miguel F. Sanmamed, Emiliano Calvo et al. · Annals of Oncology · 2020 · 17 citations · Full text

, , +11

Alectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study

Shirish M. Gadgeel, Solange Peters, Tony Mok et al. · Annals of Oncology · 2017 · 14 citations · Full text

, , +6

Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study

Tony Mok, Solange Peters, D. Ross Camidge et al. · Annals of Oncology · 2017 · 11 citations · Full text

, , +6

1–4 of 4